India study aims to match depression patients to best therapy or drug

NCT ID NCT05944926

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study in India tests two common depression treatments—a talk therapy called the Healthy Activity Program and the antidepressant fluoxetine—in 1,500 adults with moderate to severe depression. The goal is to see which treatment works best for different people and to compare costs. Results could help doctors choose the right treatment for each patient.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sangath

    Bhopal, Madhya Pradesh, 462016, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.